8 results
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
Upper Extremity ... and Anatomy Deep ... #Superficial #Deep ... #VTE #DVT #Hematology ... Management #Anatomy #Anticoagulation
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
anticoagulant dosing ... and bridging for VTE ... Clotmaster #VTE ... Anticoagulant #Anticoagulation ... #Dabigatran #Apixaban
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Lower Extremity ... and Anatomy Deep ... #Superficial #Deep ... #VTE #DVT #Hematology ... Management #Anatomy #Anticoagulation
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
Fibrillation, VTE ... Prophylaxis, VTE ... : Apixaban (25% ... OralAnticoagulant #Anticoagulation ... #Pharmacology #Apixaban
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
patients with VTE ... Fibrillation requiring anticoagulation ... overview of the dosing ... rivaroxaban for VTE ... #Rivaroxaban #Dosing
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for appropriate dosing ... DVT = deep vein ... body mass index; VTE ... #DOAC #VTE #Malignancy ... Cancer #Algorithm #Anticoagulation
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Thrombosis • Upper ... Extremity DVT: ... or more lower extremity ... DeLoughery @Bloodman #VTE ... #anticoagulation
Summary of Oncologic Emergencies

Neutropenic fever:
- Fever + ANC < 500 → start cefepime ± vancomycin (if
24-48 h and ANC rising ... compression: - Lower-extremity ... swelling, dyspnea, upper-extremity ... stenting - Consider anticoagulation ... and APL (~25 %) during